time window
Showing 1 - 25 of >10,000
Acute Ischemic Stroke, Basilar Artery Occlusion Trial in Beijing (Best medical management, Endovascular treatment)
Recruiting
- Acute Ischemic Stroke
- Basilar Artery Occlusion
- Best medical management
- Endovascular treatment
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Oct 20, 2023
Stroke, Acute Ischemic Trial (Intravenous thrombolysis agents, endovascular thrombectomy)
Not yet recruiting
- Stroke, Acute Ischemic
- Intravenous thrombolysis agents
- endovascular thrombectomy
- (no location specified)
Nov 21, 2022
Acute Ischemic Stroke Trial (rhTNK-tPA, Antiplatelet Agents)
Not yet recruiting
- Acute Ischemic Stroke
- rhTNK-tPA
- Antiplatelet Agents
- (no location specified)
Mar 1, 2023
Stroke, Acute Ischemic Trial (Tissue Plasminogen Activator (Alteplase))
Not yet recruiting
- Stroke, Acute Ischemic
- Tissue Plasminogen Activator (Alteplase)
- (no location specified)
Aug 16, 2022
Stroke Trial in Shenyang (Tenecteplase)
Completed
- Stroke
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
Jul 31, 2022
Meniscus Lesion Trial in Jinzhou (early APM, delayed APM)
Recruiting
- Meniscus Lesion
- early APM
- delayed APM
-
Jinzhou, Liaoning, ChinaFirst Affiliated Hospital of Jinzhou Medical University
Dec 16, 2022
Delayed Cord Clamping, Hemoglobin, Blood Loss Trial in Liuyang, Zibo (Delayed cord clamping (30s), Delayed cord clamping (60s),
Not yet recruiting
- Delayed Cord Clamping
- +2 more
- Delayed cord clamping (30s)
- +2 more
-
Liuyang, Hunan, China
- +1 more
Aug 7, 2022
Stroke, Ischemic Trial in Shenyang (TNK-Tissue Plasminogen Activator)
Recruiting
- Stroke, Ischemic
- TNK-Tissue Plasminogen Activator
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
Feb 10, 2022
Diabetes, Type 2, Obesity, Prediabetic State Trial in Toronto (Early (7:00 - 16:00) TRE, Mid (9:30 - 18:30) TRE, Late (12:00 -
Not yet recruiting
- Diabetes Mellitus, Type 2
- +3 more
- Early (7:00 - 16:00) TRE
- +2 more
-
Toronto, Ontario, CanadaRemote Ontario-wide
Oct 31, 2023
Advanced Solid Tumor Trial in Shijiazhuang (Camrelizumab/sintilimab+ Standard chemo, Camrelizumab/sintilimab+
Recruiting
- Advanced Solid Tumor
- Camrelizumab/sintilimab+ Standard chemotherapy
- +2 more
-
Shijiazhuang, Hebei, ChinaThe Fourth Hospital of Hebei Medical University
Dec 8, 2021
Stroke, Stroke, Acute, Stroke, Ischemic Trial (perfusion CT)
Not yet recruiting
- Stroke
- +2 more
- perfusion CT
- (no location specified)
Jan 6, 2023
Basilar Artery Occlusion Trial in Australia (Tenecteplase, Standard Care (which may include intravenous Alteplase))
Recruiting
- Basilar Artery Occlusion
- Tenecteplase
- Standard Care (which may include intravenous Alteplase)
-
Bankstown, New South Wales, Australia
- +10 more
May 29, 2022
Brain Ischemia, Stroke Rehabilitation Trial in Nanjing (early rehabilitation)
Recruiting
- Brain Ischemia
- Stroke Rehabilitation
- early rehabilitation
-
Nanjing, Jiangsu, Chinathe First Affiliated Hospital of Nanjing Medical University (Jia
Mar 26, 2022
Cied Implantation Guidelines and Cardiac Rehabilitation
Recruiting
- Left Ventricular Systolic Dysfunction
- Myocardial Infarction
-
Pavia, ItalyICS Maugeri
Mar 15, 2023
Stroke Trial in Shanghai (Tenecteplase, nonthrombolysis drug)
Recruiting
- Stroke
- Tenecteplase
- nonthrombolysis drug
-
Shanghai, Shanghai, ChinaHuashan Hospital
Jul 4, 2022
Obesity, Pre-diabetes Trial in Davis (9 hours daily eating window, 15 hours daily eating window)
Recruiting
- Obesity
- Pre-diabetes
- 9 hours daily eating window
- 15 hours daily eating window
-
Davis, CaliforniaUniversity of California, Davis
Jun 3, 2022
Ischemic Stroke Trial in Australia (Tenecteplase, Standard Care (which may include intravenous Alteplase))
Recruiting
- Ischemic Stroke
- Tenecteplase
- Standard Care (which may include intravenous Alteplase)
-
Liverpool, New South Wales, Australia
- +6 more
Jun 15, 2021
Light Exposure, Meal Timing Trial in Boston (Bright Light, Time-restricted eating, Dim light)
Recruiting
- Light Exposure
- Meal Timing
- Bright Light
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 11, 2022
The PERFusion Use in Stroke Evaluation Study
Recruiting
- Ischemic Stroke
- Computed tomography perfusion imaging
-
San Francisco, CaliforniaCalifornia Pacific Medical Center
Apr 30, 2021
Stroke, Cerebrovascular Accident, Cerebral Infarction Trial in Canada (drug, other, behavioral)
Active, not recruiting
- Stroke
- +9 more
- Fluoxetine Hydrochloride
- +2 more
-
Calgary, Alberta, Canada
- +7 more
May 18, 2022
Supratentorial Tumors Trial in Shanghai (Mannitol)
Completed
- Supratentorial Tumors
-
Shanghai, Shanghai, ChinaFudan University affiliated Huashan Hospital
Nov 18, 2020
Stroke, Acute, Cerebral Stroke, Cerebrovascular Stroke Trial in Worldwide (Thrombectomy, Best medical care)
Recruiting
- Stroke, Acute
- +3 more
- Thrombectomy
- Best medical care
-
Graz, Austria
- +42 more
Sep 28, 2021
Endometrial Serous Adenocarcinoma Trial in United States (Biospecimen Collection, Resection, Triapine)
Recruiting
- Endometrial Serous Adenocarcinoma
- Biospecimen Collection
- +2 more
-
Coral Gables, Florida
- +5 more
Aug 23, 2022
Stroke, Ischemic Trial in Brazil (Thrombectomy)
Unknown status
- Stroke, Ischemic
- Thrombectomy
-
Fortaleza, Ceara, Brazil
- +13 more
Feb 7, 2021
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ Trial in
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Biospecimen Collection
- +4 more
-
Houston, Texas
- +2 more
Aug 17, 2022